Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
Muhammad Aasim Ali, Pharmacist at Premium Care Medical Polyclinic, shared a post on LinkedIn:
”Cancer Myelosuppression Treatment
Cancer therapy–induced myelosuppression:
Neutropenia:
Granulocyte colony-stimulating factors include:
- filgrastim
- pegfilgrastim
They act on myeloid progenitors via the G-CSF receptor to accelerate neutrophil proliferation, differentiation, and release from the bone marrow.
Pegylation prolongs half-life and allows once-per-cycle dosing.
These agents reduce febrile neutropenia risk but can cause bone pain and, rarely, splenic complications.
Anemia:
Chemotherapy-induced anemia is addressed with erythropoiesis-stimulating agents such as:
- epoetin alfa
- darbepoetin alfa
These drugs activate erythropoietin receptors on erythroid progenitors to increase erythrocyte production.
However, their use is restricted due to risks of thromboembolism and potential tumor progression, and they are generally reserved for palliative settings with careful hemoglobin targets.
Thrombocytopenia:
- Oprelvekin: a recombinant human IL-11 drug used to prevent severe thrombocytopenia and reduce the need for platelet transfusions.
It acts as a thrombopoietic growth factor that stimulates the bone marrow to produce more megakaryocytes and platelets.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy